Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis

Background:  There is disagreement about the behavior and optimal management of desmoplastic melanoma (DM), particularly regarding the incidence of lymph node (LN) involvement. Recently, investigators have noted the frequently heterogenous histologic composition of DM and have found significant diff...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cutaneous pathology 2009-04, Vol.36 (4), p.425-432
Main Authors: George, Evan, McClain, Susannah E., Slingluff, Craig L., Polissar, Nayak L., Patterson, James W.
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Dermatology
Female
Hematologic and hematopoietic diseases
Humans
Immunohistochemistry
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphatic Metastasis - pathology
Male
Medical sciences
Melanoma - classification
Melanoma - pathology
Middle Aged
Neoplasm Staging
Skin Neoplasms - classification
Skin Neoplasms - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background:  There is disagreement about the behavior and optimal management of desmoplastic melanoma (DM), particularly regarding the incidence of lymph node (LN) involvement. Recently, investigators have noted the frequently heterogenous histologic composition of DM and have found significant differences between pure desmoplastic melanoma (PDM) (≥90% comprised of histologically typical DM) and mixed desmoplastic melanoma (MDM) [≥10% DM and >10% conventional melanoma (CM)]. Method:  We reviewed 87 cases of DM comparing the histologic and clinical features of PDM (n = 44) to MDM (n = 43). Results:  At surgical staging, there were LN metastases in 5 of 23 (22%) MDM patients, whereas all 17 PDM patients had negative LN biopsies (0%) (p = 0.04). PDM was less often clinically pigmented (36% vs. 67%) and had a lower mean mitotic index (1.3 vs. 3.0). Conclusions:  There are differences between PDM and MDM, the most important of which is the incidence of LN involvement. Our findings support the clinical utility of classifying DM into pure and mixed subtypes because the negligible rate of nodal involvement in PDM does not support the routine performance of sentinel LN biopsy in this subgroup of melanoma patients. In contrast, the incidence of LN involvement in MDM is comparable to that of CM.
ISSN:0303-6987
1600-0560
DOI:10.1111/j.1600-0560.2008.01058.x